Jing-Tao Zhao

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Helicobacter Pylori

Stem Cell Transplantation

Top Venues

Therapeutic advances in gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Zhe Zhao, Pei-Ying Zou, Na-Yun Su, Yan Guo, Xing-Wei Wang, Jing-Tao Zhao, Hao Mei, Qing Shi, Bin Wang, Dong-Feng Chen, Chun-Hui Lan
High-dose dual therapy versus culture-based susceptibility-guided therapy as a rescue regimen for Helicobacter pylori infection: a randomized controlled trial. Therapeutic advances in gastroenterology 15 (2022)
Hao Mei, Yan Guo, Jing-Tao Zhao, Jun Yang, Wen-Jing Sun, De-Kui Zhang, Ping He, Gang Shi, Na-Yun Su, Ran Han, Chun-Hui Lan
Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori infection: a multicenter, randomized controlled clinical trial. Therapeutic advances in gastroenterology 15 (2022)
Hao Mei, Yan Guo, Jing-Tao Zhao, Jun Yang, Wen-Jing Sun, De-Kui Zhang, Ping He, Gang Shi, Na-Yun Su, Ran Han, Chun-Hui Lan
Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori infection: a multicenter, randomized controlled clinical trial. Therapeutic advances in gastroenterology 15 (2022)
Zhe Zhao, Pei-Ying Zou, Na-Yun Su, Yan Guo, Xing-Wei Wang, Jing-Tao Zhao, Hao Mei, Qing Shi, Bin Wang, Dong-Feng Chen, Chun-Hui Lan
High-dose dual therapy versus culture-based susceptibility-guided therapy as a rescue regimen for Helicobacter pylori infection: a randomized controlled trial. Therapeutic advances in gastroenterology 15 (2022)